Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NFE2L2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | NFE2L2 |
| Full Name | Nuclear Factor Erythroid 2-Related Factor 2 |
| Chromosome | 2q31 |
| Protein Family | bZIP transcription factor family, Cap'n'collar subfamily |
| Pathways | Autophagy, Chaperone, Epigenetic, Ferroptosis, Glutathione Synthesis |
| UniProt ID | Q16236 |
| NCBI Gene ID | 4780 |
| Ensembl ID | ENSG00000116044 |
| OMIM | 604992 |
| GeneCards | NFE2L2 |
| Human Protein Atlas | NFE2L2 |
| Associated Diseases | Als, Amyotrophic Lateral Sclerosis, Cancer, Carcinoma, Hepatomegaly, Hepatoprotection |
| Known Drugs/Compounds | SFN, Ml385, Dimethyl Fumarate, Itaconate, Pterostilbene, dexamethasone |
| Interactions | HMOX1, FER, C1Q, HTRA2, MTOR, SIRT3 |
| KG Connections | 883 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
NFE2L2["NFE2L2"] -->|"Activates"| HMOX1["HMOX1"]
NFE2L2["NFE2L2"] -->|"Regulates"| SOD["SOD"]
NFE2L2["NFE2L2"] -->|"Regulates"| GPX["GPX"]
NFE2L2["NFE2L2"] -->|"Regulates"| oxidative_stress["oxidative stress"]
NFE2L2["NFE2L2"] -->|"Regulates"| antioxidant_response["antioxidant response"]
NFE2L2["NFE2L2"] -->|"Regulates"| detoxifying_enzymes["detoxifying enzymes"]
NFE2L2["NFE2L2"] -->|"Activates"| Cancer["Cancer"]
NFE2L2["NFE2L2"] -->|"Activates"| Ms["Ms"]
SQSTM1G427R["SQSTM1G427R"] -->|"Impairs"| NFE2L2["NFE2L2"]
SQSTM1["SQSTM1"] -->|"Regulates"| NFE2L2["NFE2L2"]
arsenic["arsenic"] -->|"Modulates"| NFE2L2["NFE2L2"]
HACE1["HACE1"] -->|"Interacts With"| NFE2L2["NFE2L2"]
SFN["SFN"] -->|"Activates"| NFE2L2["NFE2L2"]
style NFE2L2 fill:#8d4900,color:#e0e0e0
style HMOX1 fill:#8d4900,color:#e0e0e0
style SOD fill:#0d47a1,color:#e0e0e0
style GPX fill:#0d47a1,color:#e0e0e0
style oxidative_stress fill:#1b5e20,color:#e0e0e0
style antioxidant_response fill:#1b5e20,color:#e0e0e0
style detoxifying_enzymes fill:#0d47a1,color:#e0e0e0
style Cancer fill:#b71c1c,color:#e0e0e0
style Ms fill:#b71c1c,color:#e0e0e0
style SQSTM1G427R fill:#0d47a1,color:#e0e0e0
style SQSTM1 fill:#0d47a1,color:#e0e0e0
style arsenic fill:#00838f,color:#e0e0e0
style HACE1 fill:#0d47a1,color:#e0e0e0
style SFN fill:#00838f,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Antioxidant Response | regulates | process | 0.95 |
| Microglial Activation | regulates | process | 0.95 |
| Hepatomegaly | causes | phenotype | 0.94 |
| Inflammation | inhibits | process | 0.92 |
| EGF | upregulates | gene | 0.91 |
| PDGF | upregulates | gene | 0.91 |
| SQSTM1 | upregulates | gene | 0.90 |
| ANTIOXIDANT ENZYMES | upregulates | enzyme | 0.90 |
| PHASE-2 ENZYMES | upregulates | enzyme | 0.90 |
| Are | component_of | pathway | 0.90 |
| HO1 | regulates | gene | 0.90 |
| HMOX1 | upregulates | gene | 0.90 |
| HMOX1 | regulates | gene | 0.90 |
| Spinal Cord Injury | targets | disease | 0.90 |
| Nerve Function Recovery | promotes | process | 0.90 |
| Antioxidant Function | mediates | process | 0.90 |
| GPX4 | upregulates | gene | 0.90 |
| SLC7A11 | upregulates | gene | 0.90 |
| Antioxidant Response | activates | pathway | 0.90 |
| Anti-Oxidative Stress Response | activates | pathway | 0.90 |
| Antioxidant Defense | mediates | process | 0.90 |
| Ferroptosis | protects_against | process | 0.90 |
| OXIDATIVE STRESS | upregulates | process | 0.90 |
| NEURODEGENERATION | protects_against | process | 0.90 |
| Autophagy | activates | pathway | 0.90 |
| ACOD1 | regulates | gene | 0.89 |
| Lipotoxicity | protects_against | process | 0.88 |
| Spinal Cord Injury | protects_against | disease | 0.88 |
| Glutathione Synthesis | regulates | pathway | 0.85 |
| Stress Resistance | mediates | phenotype | 0.85 |
| Acute Ischemic Stroke | protects_against | disease | 0.85 |
| Neurological Dysfunction | protects_against | phenotype | 0.85 |
| Iron Metabolism | regulates | process | 0.85 |
| Remyelination | promotes | process | 0.85 |
| Mitochondrial Protection | mediates | process | 0.85 |
| HO1 | upregulates | gene | 0.85 |
| NQO1 | upregulates | gene | 0.85 |
| antioxidant capacity | upregulates | phenotype | 0.85 |
| Hepatic Lipid Homeostasis | mediates | process | 0.85 |
| Cancer | regulates | disease | 0.85 |
| Cancer | protects_against | disease | 0.85 |
| Ferroptosis | upregulates | process | 0.85 |
| Neuroprotection | mediates | process | 0.85 |
| Ferroptosis | inhibits | process | 0.85 |
| NFKB | modulates | protein | 0.85 |
| PI3K-AKT | upstream_of | pathway | 0.85 |
| senescence | regulates | process | 0.85 |
| Lipid Metabolism | regulates | process | 0.85 |
| Neuroinflammation | inhibits | process | 0.85 |
| Autophagy | mediates | process | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SQSTM1 | activates | protein | 1.00 |
| KEAP1 | interacts_with | protein | 0.95 |
| TGR5 | activates | receptor | 0.95 |
| Itaconate | activates | compound | 0.95 |
| Leucocyanidin | activates | compound | 0.95 |
| SESN2 | regulates | gene | 0.95 |
| Ric | upregulates | process | 0.92 |
| Ml385 | inhibits | drug | 0.92 |
| SQSTM1G427R | inhibits | protein | 0.90 |
| SQSTM1 | regulates | protein | 0.90 |
| CUL3 | degrades | protein | 0.90 |
| RBX1 | degrades | protein | 0.90 |
| Lead | promotes | drug | 0.90 |
| Dimethyl Fumarate | activates | drug | 0.90 |
| LRRK2 | inhibits | gene | 0.90 |
| TFEB | regulates | protein | 0.90 |
| Pterostilbene | activates | compound | 0.90 |
| Quercetin | activates | compound | 0.90 |
| KEAP1 | activates | gene | 0.90 |
| AUTOPHAGY | activates | gene | 0.90 |
| SQSTM1 | upstream_of | protein | 0.88 |
| FYN | phosphorylates | protein | 0.85 |
| superoxide | activates | protein | 0.85 |
| Chronic Cerebral Hypoperfusion | downregulates | disease | 0.85 |
| White Matter Ischemia | associated_with | disease | 0.85 |
| SIRT3 | activates | gene | 0.85 |
| SIRT3 | upregulates | gene | 0.85 |
| AMPK-SIRT1 Pathway | activates | pathway | 0.85 |
| SBFI26 | downregulates | drug | 0.80 |
| NRF2 | activates | gene | 0.80 |
| P62 | activates | gene | 0.80 |
| FERROPTOSIS | activates | gene | 0.80 |
| arsenic | regulates | drug | 0.70 |
| HACE1 | interacts_with | protein | 0.70 |
| SFN | activates | drug | 0.70 |
| NRF2 | associated_with | gene | 0.70 |
| NRF2 | regulates | gene | 0.70 |
| GENES | activates | gene | 0.70 |
| AMPK | activates | gene | 0.70 |
| CANCER | therapeutic_target | gene | 0.70 |
| OXIDATIVE STRESS | activates | gene | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| OXIDATIVE STRESS | causes | gene | 0.70 |
| OXIDATIVE STRESS | associated_with | gene | 0.70 |
| VDR | activates | gene | 0.64 |
| KEAP1 | inhibits | protein | 0.64 |
| ALOX5 | activates | gene | 0.60 |
| HMOX1 | activates | gene | 0.60 |
| ALOX15 | activates | gene | 0.60 |
| ALOX12 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||